Triple‐negative breast cancer (TNBC) is a type of malignant breast cancer that represents a sub‐group of breast cancers that tests negative for oestrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2).10, 11. This evidence concerns the gene PGR and breast carcinoma.